Recent Advances in Precision Medicine Technologies, 2018 Report - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 20, 2018--The “Recent Advances in Precision Medicine Technologies” report has been added to ResearchAndMarkets.com’s offering.
The Genetic Technology TechVision Opportunity Engine (TOE) depicts the current landscape and the new life sciences trends across precision medicine. Precision medicine strategies targeting mRNA splicing, novel therapies for inherited disorders, microbiome-based therapies for inflammatory diseases, and gene editing technologies fueling personalized medicine are detailed. Clinical trials scenario related to CRISPR-based technologies is also depicted.
Key Topics Covered:
1. Innovations in Precision Medicine Platforms
Precision Medicine Strategies Targeting mRNA Splicing
Novel Therapy for Inherited Deafness
Microbiome-based Therapies for Inflammatory Bowel Disease
Gene Editing Technologies Fueling Precision Medicine
2. Clinical Trial Analysis and Key Contacts
Clinical Trial Analysis of CRISPR-based Clinical Studies
Key ContactsFor more information about this report visit https://www.researchandmarkets.com/research/km35qh/recent_advances?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180920005895/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY GENETICS PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/20/2018 04:23 PM/DISC: 09/20/2018 04:22 PM